Coeptis Therapeutics Holdings Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Coeptis Therapeutics Holdings, Inc. (COEP) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.531.473.792.180.20
Cash & Short-Term Investments0.531.473.792.180.20
Accounts Receivable0.000.040.010.000.02
Inventory0.000.000.000.000.00
Other Current Assets0.520.240.140.000.00
Total Current Assets1.051.753.942.180.22
Non-Current Assets
Property, Plant & Equipment (Net)0.070.110.070.030.07
Long-Term Investments5.690.000.000.000.00
Intangible Assets0.540.000.000.000.00
Other Non-Current Assets1.552.553.904.550.00
Total Non-Current Assets7.862.823.974.590.00
Total Assets8.914.577.926.770.30
Current Liabilities
Accounts Payable1.271.420.100.131.62
Short-Term Debt1.190.981.852.421.28
Current Portion of Long-Term Debt1.190.981.852.421.28
Accrued Liabilities0.740.560.180.200.73
Deferred Revenue0.000.000.000.001.00
Other Current Liabilities1.280.000.000.000.00
Total Current Liabilities4.512.992.172.765.28
Non-Current Liabilities
Long-Term Debt0.150.150.151.650.15
Other Non-Current Liabilities0.360.561.130.000.00
Total Non-Current Liabilities0.530.771.291.650.00
Total Liabilities5.043.763.464.415.44
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-98.23-87.36-66.09-27.55-14.10
Accumulated Other Comprehensive Income-1.56-3.500.000.000.00
Treasury Stock0.000.000.000.250.00
Additional Paid-in Capital102.9891.6770.5430.150.00
Minority Interest0.680.000.000.000.00
Shares Outstanding2.121.770.980.980.00
Total Stockholders' Equity3.190.814.452.35-5.14
Total Liabilities & Equity8.914.577.926.770.00